http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1057969-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_334b26d249dc7a2d0df884c87eab5255
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-088
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-092
filingDate 1965-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1967-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1057969-A
titleOfInvention Aryloxyamines and process for preparation
abstract Novel o-substituted aryloxyamines of the formula <FORM:1057969/C2/1> wherein R1 and R2 are either the same or different lower alkyl groups, or when taken with the amino nitrogen atom form a closed chain heterocyclic group, R3, R4 and R5 may be the same or different hydrogen or halogen atoms or lower alkyl or lower alkoxy groups or together form a methylenedioxy group; Z is oxygen or sulphur and n is 2 or 3, and the pharmaceutically acceptable acid addition salts thereof are obtained in a process which comprises reacting an aryloxyamine of the formula <FORM:1057969/C2/2> with a benzyl halide of the formula <FORM:1057969/C2/3> wherein Y is halogen, and, if desired, forming the pharmaceutically acceptable salts. The starting compounds may be obtained by reacting o-hydroxybenzaldehyde with the hydrochloride salt of a substituted aminochloroalkane to form o-(substituted amino lower alkoxy)benzaldehyde which is reduced to form the corresponding benzyl alcohol. The benzyl chloride and benzyl thio-alcohol starting compounds are obtained therefrom by treatment with thionyl chloride and sodium hydrosulphide successively. Pharmaceutical compositions having anti-spasmodic, anti-inflammatory, anti-tussive, sedative, anti-pyretic and anti-convulsive activity are administered orally or parenterally.
priorityDate 1964-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525298
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID240
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6998
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559526
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9321
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7503
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15173738
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410474980
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449545084
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28015
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545706
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531457
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410443241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547614
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451

Total number of triples: 32.